This year’s meeting, featuring expert insights from industry leaders, is designed to deliver practical, data-driven methods for validating critical assays, including those for potency and genome integrity analytics across diverse delivery platforms. Attendees will explore solutions for persistent challenges such as full/empty capsid quantification, aggregation profiling, and stability assay design. The summit will highlight strategies for aligning assays with regulatory requirements (IND, BLA, and RMAT), integrating advanced technologies like long-read sequencing and digital PCR into GMP-ready workflows, and overcoming the limitations of under-validated techniques that often slow down next-generation programs.